JP6422970B2 - 時間インジケーター機能を有する薬物送達デバイス - Google Patents
時間インジケーター機能を有する薬物送達デバイス Download PDFInfo
- Publication number
- JP6422970B2 JP6422970B2 JP2016529461A JP2016529461A JP6422970B2 JP 6422970 B2 JP6422970 B2 JP 6422970B2 JP 2016529461 A JP2016529461 A JP 2016529461A JP 2016529461 A JP2016529461 A JP 2016529461A JP 6422970 B2 JP6422970 B2 JP 6422970B2
- Authority
- JP
- Japan
- Prior art keywords
- drug
- delivery device
- display
- drug delivery
- switch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000012377 drug delivery Methods 0.000 title claims description 73
- 229940079593 drug Drugs 0.000 claims description 99
- 239000003814 drug Substances 0.000 claims description 99
- 230000000007 visual effect Effects 0.000 claims description 15
- 230000004044 response Effects 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- 230000000903 blocking effect Effects 0.000 claims description 8
- 230000009471 action Effects 0.000 claims description 4
- 238000007639 printing Methods 0.000 claims description 4
- 238000005452 bending Methods 0.000 claims description 3
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 68
- 102000004877 Insulin Human genes 0.000 description 35
- 108090001061 Insulin Proteins 0.000 description 35
- 229940125396 insulin Drugs 0.000 description 34
- 230000007246 mechanism Effects 0.000 description 30
- 238000013461 design Methods 0.000 description 24
- 238000002347 injection Methods 0.000 description 17
- 239000007924 injection Substances 0.000 description 17
- 239000011888 foil Substances 0.000 description 15
- 238000004519 manufacturing process Methods 0.000 description 12
- 210000003127 knee Anatomy 0.000 description 11
- 230000006870 function Effects 0.000 description 7
- 235000012054 meals Nutrition 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 239000004020 conductor Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000000873 masking effect Effects 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 description 2
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 description 2
- 102400000322 Glucagon-like peptide 1 Human genes 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000000712 assembly Effects 0.000 description 2
- 238000000429 assembly Methods 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000000122 growth hormone Substances 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 208000032529 Accidental overdose Diseases 0.000 description 1
- WEDIKSVWBUKTRA-WTKGVUNUSA-N CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc3ccccc3)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc3c[nH]cn3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC Chemical compound CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc3ccccc3)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc3c[nH]cn3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC WEDIKSVWBUKTRA-WTKGVUNUSA-N 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 208000031220 Hemophilia Diseases 0.000 description 1
- 208000009292 Hemophilia A Diseases 0.000 description 1
- 101000976075 Homo sapiens Insulin Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108010073961 Insulin Aspart Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 description 1
- 239000004026 insulin derivative Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001550 time effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31533—Dosing mechanisms, i.e. setting a dose
- A61M5/31535—Means improving security or handling thereof, e.g. blocking means, means preventing insufficient dosing, means allowing correction of overset dose
- A61M5/31536—Blocking means to immobilize a selected dose, e.g. to administer equal doses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31533—Dosing mechanisms, i.e. setting a dose
- A61M5/31545—Setting modes for dosing
- A61M5/31548—Mechanically operated dose setting member
- A61M5/3155—Mechanically operated dose setting member by rotational movement of dose setting member, e.g. during setting or filling of a syringe
- A61M5/31551—Mechanically operated dose setting member by rotational movement of dose setting member, e.g. during setting or filling of a syringe including axial movement of dose setting member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
- A61M5/31566—Means improving security or handling thereof
- A61M5/31568—Means keeping track of the total dose administered, e.g. since the cartridge was inserted
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
- A61M5/31576—Constructional features or modes of drive mechanisms for piston rods
- A61M5/31578—Constructional features or modes of drive mechanisms for piston rods based on axial translation, i.e. components directly operatively associated and axially moved with plunger rod
- A61M5/3158—Constructional features or modes of drive mechanisms for piston rods based on axial translation, i.e. components directly operatively associated and axially moved with plunger rod performed by axially moving actuator operated by user, e.g. an injection button
-
- G—PHYSICS
- G04—HOROLOGY
- G04G—ELECTRONIC TIME-PIECES
- G04G9/00—Visual time or date indication means
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
- G16Z99/00—Subject matter not provided for in other main groups of this subclass
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M2005/3125—Details specific display means, e.g. to indicate dose setting
- A61M2005/3126—Specific display means related to dosing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2207/00—Methods of manufacture, assembly or production
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31533—Dosing mechanisms, i.e. setting a dose
- A61M5/31545—Setting modes for dosing
- A61M5/31548—Mechanically operated dose setting member
- A61M5/3155—Mechanically operated dose setting member by rotational movement of dose setting member, e.g. during setting or filling of a syringe
- A61M5/31553—Mechanically operated dose setting member by rotational movement of dose setting member, e.g. during setting or filling of a syringe without axial movement of dose setting member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
- A61M5/31576—Constructional features or modes of drive mechanisms for piston rods
- A61M5/31583—Constructional features or modes of drive mechanisms for piston rods based on rotational translation, i.e. movement of piston rod is caused by relative rotation between the user activated actuator and the piston rod
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Veterinary Medicine (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Primary Health Care (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Description
Claims (14)
- 薬物送達デバイス(200、600)であって、
外面を有するハウジング(201)と、
薬物が充填されたカートリッジ(213)又は薬物が充填されたカートリッジを受容する手段であって、前記薬物が充填されたカートリッジは、出口と軸方向に変位可能なピストンとを備える、
薬物が充填されたカートリッジ(213)又は薬物が充填されたカートリッジを受容する手段と、
薬物吐出手段であって、
前記ピストンに係合し、前記ピストンを軸方向に動かし、これによって前記カートリッジから前記出口を通じてある量の薬物を吐出するように適合された駆動部材(220)と、
前記薬物送達デバイスにおいて又は前記薬物送達デバイスによって行われるアクションに対応して動くように構成されたインジケーター部材(450)と、
を備える、薬物吐出手段と、
可撓性シート(300、700)であって、前記可撓性シートの上に、
前記インジケーター部材の動きによって直接又は間接的に作動するように適合された入力手段(351、353)と、
時間パラメーターを表示するように適合されたディスプレイ(320、720)と、
プロセッサ(330、730)と、
エネルギー源(340、740)と、
が形成又は搭載される、可撓性シートと、
を備え、
前記プロセッサは、前記入力手段からの入力に基づいて、前記入力手段が作動した時間に関する時間パラメーターを表示するように前記ディスプレイを制御するように適合され、
前記可撓性シートは、少なくとも部分的に、前記ハウジングの外側に搭載される、薬物送達デバイス。 - 前記入力手段は、第1の状態と第2の状態との間で作動するように適合されたスイッチ構造体(351、353)の形態をとる、請求項1に記載の薬物送達デバイス。
- 前記スイッチ構造体は、前記可撓性シートの接触エリア上に形成又は搭載されるいくつかの固定接触エリア(353)を含み、前記薬物送達デバイスは、前記固定接触エリアと係合し、これにより前記入力手段を作動させるように適合された移動可能なスイッチ構造体(352、355)を更に備え、前記移動可能なスイッチ構造体は、前記インジケーター部材によって動かされるように適合される、請求項2に記載の薬物送達デバイス。
- 前記移動可能なスイッチ構造体は、前記可撓性シートと一体に形成され、前記移動可能なスイッチ構造体は接触エリア(355)を備え、前記接触エリアは、前記可撓性シートの屈曲によって前記接触エリアの動作位置に配置される、請求項3に記載の薬物送達デバイス。
- 1つ又は複数のスイッチ部材を更に備え、
前記ハウジングは開口を備え、
前記1つ又は複数のスイッチ部材は、前記開口に対応して配置され、少なくとも1つのスイッチ部材が、前記開口内に突き出し、前記インジケーター部材によって動かされるように適合された移動可能なスイッチ部材であり、これによって、前記1つ又は複数のスイッチ部材が、第1の状態と第2の状態との間で作動するように適合されたスイッチアセンブリを形成し、
前記可撓性シートは、前記開口を覆うように搭載され、前記可撓性シートは、前記スイッチアセンブリに係合し、これによって前記入力手段を提供するように適合された接触手段を備える、請求項1又は2に記載の薬物送達デバイス。 - 前記インジケーター部材(450)は、設定投与量に対応する設定位置から、前記設計投与量が吐出された投与終了位置まで回転するように適合され、
前記入力手段は、前記インジケーター部材が前記投与終了位置に達したときに作動し、
前記プロセッサは、
入力手段が作動した時間を示す時間パラメーター、又は、
入力手段が作動してからの時間を示す時間パラメーター(721、722)
を表示するように前記ディスプレイ(720)を制御するように適合される、請求項1から5のいずれか一項に記載の薬物送達デバイス。 - 前記インジケーター部材(450)は、前記薬物吐出手段が投与量設定状態にあるときに第1の軸方向の位置を有し、前記薬物吐出手段が吐出状態にあるときに第2の軸方向の位置を有し、前記入力手段は、前記インジケーター部材が前記第2の軸方向位置にある状態においてのみ、前記インジケーター部材によって作動するように適合される、請求項6に記載の薬物送達デバイス。
- 前記インジケーター部材(450)は、投与量が設定されると、初期位置から設定位置まで動くように適合され、
前記入力手段は、前記インジケーター部材が前記初期位置から離れるように動かされると作動し、
前記プロセッサは、
入力手段が作動した時間を示す時間パラメーター、又は、
入力手段が作動してからの時間を示す時間パラメーター(721、722)
を表示するように前記ディスプレイ(720)を制御するように適合される、請求項1から5のいずれか一項に記載の薬物送達デバイス。 - インジケーター部材(280、230)が、薬物の設定量及び/又は吐出量に対応して動くように適合され、
前記入力手段(1610、1620、1920、1930)及び前記プロセッサは、前記薬物の設定量及び/又は吐出量を検出するように適合され、
前記ディスプレイは、薬物の量に対応する値を表示するように適合される、請求項1から8のいずれか一項に記載の薬物送達デバイス。 - 前記ハウジング(601)は湾曲した外面部分を有し、
前記可撓性シート(700)及び前記ディスプレイ(720)は、前記ハウジングの前記湾曲した外面部分に少なくとも部分的に搭載される、請求項1から9のいずれか一項に記載の薬物送達デバイス。 - 前記入力手段(750)、ディスプレイ(720)、プロセッサ及びエネルギー源のうちの1つ若しくは複数又は全てがプリンテッドエレクトロニクスの形態をとる、請求項1から10のいずれか一項に記載の薬物送達デバイス。
- プリントによって前記可撓性シート上にアンテナが形成され、前記プロセッサは、前記アンテナを介して外部受信機との間でデータを送信又は受信するように適合される、請求項1から11のいずれか一項に記載の薬物送達デバイス。
- 第1のタイプの薬物を含む、薬物が充填されたカートリッジ(2210)と、
前記第1のタイプの薬物を示す第1の視覚インジケーター(2211)と、
前記第1のタイプの薬物を示す第2の視覚インジケーターに関連付けられた第1のユーザー入力手段(2202)と、
第2のタイプの薬物を示す第3の視覚インジケーターに関連付けられた第2のユーザー入力手段(2203)と、
前記薬物吐出手段の通常動作を阻止する第1の状態と、前記薬物吐出手段の通常動作を可能にする第2の状態とを有するブロック手段(2204)と、
を備え、
前記第1のユーザー入力手段の作動によって、前記ブロック手段が前記第1の状態から前記第2の状態に入り、これによって、前記薬物吐出手段の通常動作が可能になり、
前記第2のユーザー入力手段の作動によって、前記ブロック手段は前記第1の状態から前記第2の状態に入らず、これによって、前記薬物吐出手段の通常動作が阻止される、請求項1から12のいずれか一項に記載の薬物送達デバイス(2200)。 - 薬物送達デバイスを組み立てる方法であって、
(i)
(a)完全に又は部分的に組み立てられた薬物送達デバイスであって、
外面及び開口(2009)を有するハウジング(2001)と、
前記ハウジングの内面に配置される薬物吐出手段であって、前記薬物送達デバイスにおいて又は前記薬物送達デバイスによって行われるアクションに対応して動くように構成されたインジケーター部材(250)を備える、薬物吐出手段と、
を備える、薬物送達デバイスと、
(b)前記開口に少なくとも部分的に搭載され、前記インジケーター部材によって作動するように適合されたスイッチ手段(2110、2120、2130)であって、接触端子を備える、スイッチ手段と、
(c)可撓性シートであって、前記可撓性シートの上に、
入力端子と、
時間パラメーターを表示するように適合されたディスプレイ(320、720)と、
前記入力端子からの入力に基づいて、前記入力が検出された時間に関係する時間パラメーターを表示するように前記ディスプレイを制御するように適合されたプロセッサ(330、730)と、
エネルギー源(340、740)と、
が形成又は搭載される、可撓性シートと、
を設けることと、
(ii)前記開口に対応して前記ハウジングに前記スイッチ手段を搭載することと、
(iii)前記可撓性シートを、前記ハウジング外面に搭載することであって、前記入力端子は前記スイッチ手段の接触端子に連動し、前記可撓性シートは前記開口を覆うことと、
を含む、方法。
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13192790 | 2013-11-13 | ||
| EP13192790.7 | 2013-11-13 | ||
| US201361906979P | 2013-11-21 | 2013-11-21 | |
| US61/906,979 | 2013-11-21 | ||
| EP14169056.0 | 2014-05-20 | ||
| EP14169056 | 2014-05-20 | ||
| PCT/EP2014/074475 WO2015071354A1 (en) | 2013-11-13 | 2014-11-13 | Drug delivery device with time indicator feature |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016540555A JP2016540555A (ja) | 2016-12-28 |
| JP6422970B2 true JP6422970B2 (ja) | 2018-11-14 |
Family
ID=53056815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016529461A Expired - Fee Related JP6422970B2 (ja) | 2013-11-13 | 2014-11-13 | 時間インジケーター機能を有する薬物送達デバイス |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10226577B2 (ja) |
| EP (1) | EP3068468B1 (ja) |
| JP (1) | JP6422970B2 (ja) |
| CN (1) | CN105705184B (ja) |
| WO (1) | WO2015071354A1 (ja) |
Families Citing this family (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015061574A2 (en) * | 2013-10-23 | 2015-04-30 | Dock Technologies Inc. | Indicators |
| US20150301778A1 (en) * | 2014-04-22 | 2015-10-22 | Samsung Electro-Mechanics Co., Ltd. | Electronic shelf label having near field communication (nfc) function embedded therein |
| USD773646S1 (en) * | 2014-08-27 | 2016-12-06 | Merck Sharp & Dohme Corp | Medical injector pen |
| USD777907S1 (en) * | 2014-08-27 | 2017-01-31 | Merck Sharp & Dohme Corp. | Medical injector pen |
| WO2016193122A1 (en) | 2015-05-29 | 2016-12-08 | Novo Nordisk A/S | Power efficient electronic device |
| CA2934675A1 (en) * | 2015-07-02 | 2017-01-02 | Mabe, S.A. De C.V. | Multi burner ovni |
| EP3322461B1 (en) * | 2015-07-13 | 2022-01-26 | Novo Nordisk A/S | Pen-type drug injector with end-of-dose sensor and system for registering the delivered dose |
| EP3192546A1 (en) | 2016-01-12 | 2017-07-19 | Novo Nordisk A/S | Drug delivery device with improved dose accuracy |
| CH711618A2 (en) | 2015-10-07 | 2017-04-13 | Tecpharma Licensing Ag | Administration device with activatable identification means. |
| EP3374009B1 (en) * | 2015-11-11 | 2021-01-06 | Novo Nordisk A/S | Drug delivery device with information capture |
| EP3178507A1 (en) | 2015-12-09 | 2017-06-14 | Carebay Europe Ltd. | Communication device for transmitting information from a medicament delivery device |
| EP3184137A1 (en) | 2015-12-23 | 2017-06-28 | Carebay Europe Ltd. | Medicament delivery device with user feedback capability |
| US10671179B2 (en) * | 2015-12-30 | 2020-06-02 | Shenzhen Royole Technologies Co., Ltd. | Rollable and flexible input device |
| US10864327B2 (en) | 2016-01-29 | 2020-12-15 | Companion Medical, Inc. | Automatic medication delivery tracking |
| JP6483334B1 (ja) * | 2016-02-22 | 2019-03-13 | ウエスト ファーマスーティカル サービシーズ インコーポレイテッド | 医療デバイスのためのラベリング装置 |
| DE102016106655A1 (de) * | 2016-04-12 | 2017-10-12 | B. Braun Avitum Ag | Medizintechnisches Gerät mit Monitoreinrichtung |
| WO2017207495A1 (en) | 2016-05-30 | 2017-12-07 | Novo Nordisk A/S | Mounting feature for accessory device |
| WO2017207496A1 (en) | 2016-05-30 | 2017-12-07 | Novo Nordisk A/S | Drug delivery device with zero position adjustment feature |
| WO2018015242A1 (en) | 2016-07-21 | 2018-01-25 | Novo Nordisk A/S | Drug delivery device for detection of an end-of-dose |
| US9636464B1 (en) * | 2016-08-01 | 2017-05-02 | Innovative Precision Instruments Limited | Drug delivery device and a drug information detection device |
| JP2019532745A (ja) | 2016-10-31 | 2019-11-14 | ノボ・ノルデイスク・エー/エス | 偏向可能なハウジング部分を備えた薬剤注射デバイス |
| AU2017387077B2 (en) * | 2016-12-28 | 2023-07-27 | Genentech, Inc. | Injection monitoring device |
| JP7018449B2 (ja) | 2017-02-01 | 2022-02-10 | ノボ・ノルデイスク・エー/エス | 使い捨てペン式薬剤送達装置用およびその内部の回転式用量センシングモジュール |
| EP3381494A1 (en) * | 2017-03-30 | 2018-10-03 | Tecpharma Licensing AG | Monitoring an injection process |
| WO2018185317A1 (en) * | 2017-04-07 | 2018-10-11 | Novo Nordisk A/S | End-of-content mechanism |
| WO2018206439A1 (en) | 2017-05-09 | 2018-11-15 | Novo Nordisk A/S | Flexible electronic label device |
| EP3621680A1 (en) * | 2017-05-09 | 2020-03-18 | Novo Nordisk A/S | Drug delivery device with sound transducer |
| JP7033611B2 (ja) * | 2017-05-11 | 2022-03-10 | ノボ・ノルデイスク・エー/エス | ピストンロッドブレーキ機構 |
| KR102658959B1 (ko) | 2017-06-30 | 2024-04-22 | 리제너론 파아마슈티컬스, 인크. | 안티 롤 피쳐를 갖는 자동 주입기 |
| US20190022328A1 (en) * | 2017-07-21 | 2019-01-24 | Verily Life Sciences Llc | Dosage measurement system in a pen button |
| US20210008296A1 (en) | 2017-09-14 | 2021-01-14 | Novo Nordisk A/S | Injection device with means for determining expelled dose |
| JP1629608S (ja) | 2017-10-25 | 2019-04-15 | ||
| WO2019101962A1 (en) | 2017-11-23 | 2019-05-31 | Sanofi | Medicament injection device with rotary encoder |
| EP3720524B1 (en) * | 2017-12-04 | 2023-10-18 | Novo Nordisk A/S | Drug injection device with deflectable transducers |
| US11464459B2 (en) | 2017-12-12 | 2022-10-11 | Bigfoot Biomedical, Inc. | User interface for diabetes management systems including flash glucose monitor |
| JP7512203B2 (ja) | 2017-12-12 | 2024-07-08 | ビッグフット バイオメディカル インコーポレイテッド | 治療支援情報及び/又は追跡装置並びに関連する方法及びシステム |
| US11083852B2 (en) | 2017-12-12 | 2021-08-10 | Bigfoot Biomedical, Inc. | Insulin injection assistance systems, methods, and devices |
| US11116899B2 (en) | 2017-12-12 | 2021-09-14 | Bigfoot Biomedical, Inc. | User interface for diabetes management systems and devices |
| US11197964B2 (en) | 2017-12-12 | 2021-12-14 | Bigfoot Biomedical, Inc. | Pen cap for medication injection pen having temperature sensor |
| US11077243B2 (en) | 2017-12-12 | 2021-08-03 | Bigfoot Biomedical, Inc. | Devices, systems, and methods for estimating active medication from injections |
| US10987464B2 (en) | 2017-12-12 | 2021-04-27 | Bigfoot Biomedical, Inc. | Pen cap for insulin injection pens and associated methods and systems |
| CN115814208B (zh) * | 2017-12-18 | 2026-01-30 | 赛诺菲 | 用于注射装置的旋转传感器 |
| EP3731899B1 (en) * | 2017-12-28 | 2024-10-23 | Sanofi | Mounting adapter for injection device and add-on device |
| WO2019149918A1 (en) | 2018-02-02 | 2019-08-08 | Novo Nordisk A/S | Drug injection device with deflectable transducer |
| EP3762940A1 (en) | 2018-03-09 | 2021-01-13 | Novo Nordisk A/S | Transmission protocol for medical device with logging feature |
| WO2019193020A1 (en) | 2018-04-02 | 2019-10-10 | Novo Nordisk A/S | Drug injection device with switch arrangement |
| JP2021519979A (ja) | 2018-04-03 | 2021-08-12 | ノボ・ノルデイスク・エー/エス | 安全なデータ送信機能 |
| US11007325B2 (en) | 2018-04-24 | 2021-05-18 | Veriliy Life Sciences LLC | Dosage tracking apparatus, dosage tracking system, and related methods of use |
| IL278443B2 (en) * | 2018-05-04 | 2025-07-01 | Bigfoot Biomedical Inc | Therapy devices, methods, and systems including a piston-style detector |
| CN112118882B (zh) | 2018-05-17 | 2023-03-21 | 赛诺菲 | 用于注射装置的触敏标签 |
| WO2019219825A1 (en) | 2018-05-18 | 2019-11-21 | Novo Nordisk A/S | Drug delivery assembly with information capture |
| EP3572107A1 (en) * | 2018-05-22 | 2019-11-27 | Tecpharma Licensing AG | Click event identification in delivery devices |
| USD932006S1 (en) | 2018-11-21 | 2021-09-28 | Regeneron Pharmaceuticals, Inc. | Auto-injector cap |
| USD903856S1 (en) | 2018-06-29 | 2020-12-01 | Regeneron Pharmaceuticals, Inc. | Auto-injector |
| ES2926591T3 (es) | 2018-10-03 | 2022-10-27 | Lilly Co Eli | Sistemas de detección de estados dentro de un ensamblaje de dispositivo de inyección |
| US12205699B1 (en) | 2018-10-30 | 2025-01-21 | Bigfoot Biomedical, Inc. | Method of pairing therapy devices using shared secrets, and related systems, methods and devices |
| JP7430186B2 (ja) * | 2018-11-23 | 2024-02-09 | サノフイ | 薬物送達デバイス用の電子インクラベル |
| CN113164690B (zh) * | 2018-12-04 | 2023-12-22 | 诺和诺德股份有限公司 | 具有移动传感器系统的药物递送组件 |
| JP2022522171A (ja) * | 2019-02-27 | 2022-04-14 | ノボ・ノルデイスク・エー/エス | 吐出用量を決定するための手段を有する薬剤送達装置 |
| US11948671B2 (en) | 2019-04-11 | 2024-04-02 | Medtronic Minimed, Inc. | Intelligent accessories for medicine dispensing device |
| BR112021026240A2 (pt) * | 2019-06-26 | 2022-06-07 | Sanofi Sa | Dispositivo de injeção |
| US20220379040A1 (en) | 2019-10-08 | 2022-12-01 | Novo Nordisk A/S | Dose sensing module with friction enhancing means |
| US20230108921A1 (en) * | 2019-10-28 | 2023-04-06 | Sanofi | Electronic Label for a Drug Delivery Device |
| WO2021083824A2 (en) * | 2019-10-28 | 2021-05-06 | Sanofi | Label for an injection device |
| CA3063247A1 (en) * | 2019-10-30 | 2021-04-30 | Intelligent Devices Sezc Inc. | Dynamic display for package monitoring |
| WO2021191322A1 (en) * | 2020-03-27 | 2021-09-30 | Sanofi | Electronic system for a drug delivery device and drug delivery device |
| WO2021260007A1 (en) * | 2020-06-25 | 2021-12-30 | Sanofi | A training device, system and method |
| WO2022046596A1 (en) * | 2020-08-26 | 2022-03-03 | Eli Lilly And Company | Medication delivery device with sensing system |
| US20240001038A1 (en) | 2020-11-24 | 2024-01-04 | Novo Nordisk A/S | Fast data transmission feature for medical logging device |
| US11803723B2 (en) * | 2022-03-14 | 2023-10-31 | Hart Intercivic, Inc. | Electronic display tags for tracking election equipment |
| US12502486B2 (en) * | 2022-03-14 | 2025-12-23 | Medtronic Minimed, Inc. | Safeguards against usage of incorrect portable medicine delivery devices |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5536249A (en) * | 1994-03-09 | 1996-07-16 | Visionary Medical Products, Inc. | Pen-type injector with a microprocessor and blood characteristic monitor |
| AU708528B2 (en) * | 1996-02-23 | 1999-08-05 | Novo Nordisk A/S | Syringe with electronic representation of parameters |
| FI109272B (fi) | 1998-02-26 | 2002-06-28 | Raimo Juselius | Ottotapahtuman ilmaisinlaite ja menetelmä ottotapahtuman ilmaisemiseksi |
| RU2508922C2 (ru) | 2008-08-29 | 2014-03-10 | Ново Нордиск А/С | Медицинское инъекционное устройство с индикатором временной задержки |
| EP2335755A1 (en) | 2009-12-17 | 2011-06-22 | Sanofi-Aventis Deutschland GmbH | Device and method for delivery of two or more drug agents |
| DE102010042007B4 (de) * | 2010-10-05 | 2013-04-04 | Aptar Radolfzell Gmbh | Austragvorrichtung für pharmazeutische Medien |
| JP6106666B2 (ja) | 2011-07-07 | 2017-04-05 | ノボ・ノルデイスク・エー/エス | アドオン式の投薬取得/表示モジュールを備える薬剤送出注射ペン |
-
2014
- 2014-11-13 US US15/035,040 patent/US10226577B2/en active Active
- 2014-11-13 JP JP2016529461A patent/JP6422970B2/ja not_active Expired - Fee Related
- 2014-11-13 CN CN201480062383.3A patent/CN105705184B/zh not_active Expired - Fee Related
- 2014-11-13 EP EP14798833.1A patent/EP3068468B1/en active Active
- 2014-11-13 WO PCT/EP2014/074475 patent/WO2015071354A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015071354A1 (en) | 2015-05-21 |
| JP2016540555A (ja) | 2016-12-28 |
| US10226577B2 (en) | 2019-03-12 |
| CN105705184B (zh) | 2019-07-26 |
| CN105705184A (zh) | 2016-06-22 |
| EP3068468A1 (en) | 2016-09-21 |
| US20160263327A1 (en) | 2016-09-15 |
| EP3068468B1 (en) | 2018-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6422970B2 (ja) | 時間インジケーター機能を有する薬物送達デバイス | |
| JP2018515232A (ja) | 薬剤送達装置のための回転センサ構造体 | |
| CN108136136B (zh) | 低功耗的附加装置 | |
| EP2958611B1 (en) | Rotary sensor module with axial switch | |
| EP3209351B1 (en) | Pen-type drug delivery device with electronic display on clip member | |
| EP3071262B1 (en) | Rotary sensor assembly with space efficient design | |
| CN108348695B (zh) | 具有信息捕获的药物输送装置 | |
| JP2016506845A (ja) | 用量捕捉モジュールを有する薬剤送達装置 | |
| JP2019500142A (ja) | 低電力フィーチャーを備えたロータリーセンサアセンブリ | |
| CN109069756B (zh) | 具有剂量捕获的药物输送系统 | |
| US12011573B2 (en) | Touch sensitive label for an injection device | |
| JP2021522955A (ja) | 情報取り込みを有する薬剤送達組立品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20171025 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20180910 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20180918 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20181017 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6422970 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |